Polyethylene

Polyethylene

9002-88-4

Sigma-Aldrich

https://www.sigmaaldrich.com/US/en/sds/aldrich/428043

2024

Polymer

gabriel_salierno@uml.edu

Yes

51

6.30

4

6

10

10

2

3

5

10

{"5":{"value":"4","score":4},"8":{"value":"8000","score":2,"memo":"LD50 Oral - Rat - > 8,000 mg\/kg Remarks: (RTECS)"},"9":{"value":"2","score":2},"13":{"value":"4","score":4},"19":{"value":"4","score":4},"22":{"value":"4","score":4},"29":{"value":"2","score":2},"30":{"value":"4","score":4,"memo":"Pharos (LT-UNK): Group 3 - Agent is not classifiable as to its carcinogenicity to humans"},"33":{"value":"2","score":2},"34":{"value":"2","score":2},"38":{"value":"4","score":4},"41":{"value":"4","score":4},"49":{"value":"8","score":8},"50":{"value":"8","score":8,"memo":"Pharos: Quebec CSST - Asthma Agents Agent Causing Occupational Asthma"},"55":{"value":"2","score":2},"64":{"value":"0.000000000123","score":10,"memo":"EPI Suite"},"65":{"value":"0.00000000648","score":10,"memo":"EPI Suite"},"66":{"value":"6","score":6,"memo":"EPI Suite - chemical may not be soluble enough to measure the predicted effect"},"70":{"value":"0.0000000374","score":10,"memo":"EPI Suite - chemical may not be soluble enough to measure the predicted effect"},"71":{"value":"6","score":6,"memo":"EPI Suite - chemical may not be soluble enough to measure the predicted effect"},"79":{"value":"0.24","score":4,"memo":"EPI Suite"},"77":{"value":"37.5","score":8,"memo":"EPI Suite"},"81":{"value":"75","score":8,"memo":"EPI Suite"},"83":{"value":"10","score":10,"memo":"Pharos: EC - CEPA DSL Persistent"},"88":{"value":"8","score":8,"memo":"EPI Suite"},"89":{"value":"17.04","score":10,"memo":"EPI Suite"},"90":{"value":"0.925","score":2,"memo":"EPI Suite"},"92":{"value":"6","score":6},"94":{"value":"2","score":2},"97":{"value":"2","score":2},"99":{"value":"2","score":2},"98":{"value":"2","score":2},"101":{"value":"2","score":2},"100":{"value":"2","score":2},"103":{"value":"4","score":4},"106":{"value":"221","score":2,"memo":"NTP ChemicalRepository 2001"},"110":{"value":"2","score":2},"111":{"value":"2","score":2},"113":{"value":"","score":""},"114":{"value":"2","score":2},"115":{"value":"2","score":2},"117":{"value":"2","score":2},"125":{"value":"4","score":4},"126":{"value":"4","score":4},"141":{"value":"6","score":6},"142":{"value":"4","score":4},"153":{"value":"10","score":10},"146":{"value":"6","score":6,"memo":"https:\/\/doi.org\/10.1016\/j.heliyon.2018.e01020"},"147":{"value":"10","score":10,"memo":"Microplastic formation potential"},"148":{"value":"8","score":8},"150":{"value":"100","score":2}}

4

8000

LD50 Oral - Rat - > 8,000 mg/kg Remarks: (RTECS)

2

4

4

4

2

4

Pharos (LT-UNK): Group 3 - Agent is not classifiable as to its carcinogenicity to humans

2

2

4

4

8

8

Pharos: Quebec CSST - Asthma Agents Agent Causing Occupational Asthma

2

0.000000000123

EPI Suite

0.00000000648

EPI Suite

6

EPI Suite - chemical may not be soluble enough to measure the predicted effect

0.0000000374

EPI Suite - chemical may not be soluble enough to measure the predicted effect

6

EPI Suite - chemical may not be soluble enough to measure the predicted effect

37.5

EPI Suite

0.24

EPI Suite

75

EPI Suite

10

Pharos: EC - CEPA DSL Persistent

8

EPI Suite

17.04

EPI Suite

0.925

EPI Suite

6

2

2

2

2

2

2

0

4

221

NTP ChemicalRepository 2001

2

2

2

2

2

4

4

6

4

6

https://doi.org/10.1016/j.heliyon.2018.e01020

10

Microplastic formation potential

8

100

0

10